Don't miss out on the highly anticipated third quarter financial results of Boston Scientific (NYSE: BSX) set to be unveiled on Wednesday 23rd October 2024. Be prepared to seize this valuable opportunity to analyze the company's financial performance before market open.
As per the projections made by financial experts on Wall Street, the enterprise is expected to announce an estimated $0.59 profit per share for the quarter. Moreover, the firm is likely to disclose a quarterly revenue of $4.04 billion.
The company's yearly performance has been analyzed by Wall Street analysts, who have projected a total revenue of $16.28 billion. Additionally, they are expecting the company to achieve a per share profit of $2.41 for the fiscal year 2024.
In the same quarter of the previous year, the company's financial statement revealed a per-share income of $0.5. Additionally, the company's overall revenue for that particular period was an impressive $3.53 billion.
| Period | EPS Actual |
EPS Growth* |
Revenue Actual |
Revenue Growth* |
|---|---|---|---|---|
| Historical Earnings Insight | ||||
| Q2 2024 | $0.62 | +17.0% | 4.12 B | +14.5% |
| Q1 2024 | $0.56 | +19.1% | 3.86 B | +13.8% |
| Q4 2023 | $0.55 | +22.2% | 3.73 B | +14.9% |
| Q3 2023 | $0.50 | +16.3% | 3.53 B | +11.3% |
| Q2 2023 | $0.53 | +20.5% | 3.60 B | +10.9% |
| *Growth on year-over-year basis | ||||
BSX will host a conference call with investment community on 23rd October 2024 at 08:00 AM eastern time to discuss the financial results.
Throughout the trading day, Boston Scientific (BSX) shares fluctuated between $87.87 and $88.79, with a trading volume of 5.61 million shares. The stock ended the regular trading session at $88.05, showing fall of 0.02 percent.
